Immune checkpoint inhibitors (ICIs) are a novel class of immunotherapy drugs that have
improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small …

Lung transplantation offers a survival benefit in well chosen patients with end-stage lung
diseases. However, CLAD, side effects of immunosuppressive therapy and solid organ …

Lung transplantation (LTx) can be a life-extending treatment option for patients with
advanced and/or progressive fibrotic interstitial lung disease (ILD), especially idiopathic …

As lung transplantation has become the most effective definitive treatment option for end-
stage chronic respiratory diseases, yearly rates of this surgery have been steadily …

Lung transplantation is an established therapeutic option for selected patients with
advanced lung diseases. As early outcomes after lung transplantation have improved …

Understanding the cancer risks in different transplant recipients helps early detection,
evaluation, and treatment of post-transplant malignancies. Therefore, we performed a meta …

The advent in the last several years of effective immunotherapy for cancer has renewed
interest in the role of the immune system in controlling cancer. The idea that the immune …

Background Interstitial lung disease associated with genetic disorders of the surfactant
system is a rare entity in adults that can lead to lung transplantation. Our objective was to …

Simple Summary Lung transplant recipients are at high risk of malignancies. Despite the
continuous improvements in lung transplant outcomes over time, limited knowledge exists …

Background. Solid organ transplant recipients (ie,“recipients”) have elevated cancer risk and
reduced survival after a cancer diagnosis. Evaluation of cancer mortality among recipients …